A detailed history of Quent Capital, LLC transactions in Incyte Corp stock. As of the latest transaction made, Quent Capital, LLC holds 81 shares of INCY stock, worth $6,234. This represents 0.0% of its overall portfolio holdings.

Number of Shares
81
Previous 72 12.5%
Holding current value
$6,234
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$57.33 - $68.61 $515 - $617
9 Added 12.5%
81 $5,000
Q2 2024

Jul 08, 2024

BUY
$51.18 - $63.75 $1,688 - $2,103
33 Added 84.62%
72 $4,000
Q1 2024

May 02, 2024

SELL
$56.55 - $66.59 $904 - $1,065
-16 Reduced 29.09%
39 $2,000
Q4 2023

Jun 14, 2024

BUY
$52.16 - $64.19 $2,295 - $2,824
44 Added 400.0%
55 $3,000
Q4 2023

Jan 19, 2024

BUY
$52.16 - $64.19 $2,295 - $2,824
44 Added 400.0%
55 $3,000
Q2 2023

Jun 14, 2024

SELL
$60.95 - $75.51 $1,706 - $2,114
-28 Reduced 71.79%
11 $0
Q2 2023

Jul 10, 2023

SELL
$60.95 - $75.51 $1,706 - $2,114
-28 Reduced 71.79%
11 $0
Q2 2022

Aug 08, 2022

BUY
$66.18 - $83.18 $397 - $499
6 Added 18.18%
39 $3,000
Q1 2022

May 12, 2022

BUY
$66.02 - $79.71 $2,178 - $2,630
33 New
33 $3,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $17.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.